In the ever-evolving landscape of cancer care, technological advancements continue to drive remarkable progress in treatments and research. As we delve into the dynamic realm of oncology, it is imperative to recognize the groundbreaking innovations that are emerging, globally. Keeping abreast with all the technological advancements in cancer care and bringing a ray of hope to 3.5 billion population from 147 countries, Apollo Cancer Centres is at the forefront of this transformative journey.
Technological Advancements in Cancer Treatment
The field of oncology has witnessed a remarkable surge in technological advancements, offering unprecedented avenues for precision and efficacy in cancer treatment. Across the globe, cutting-edge technologies such as Proton Therapy, Robotic Surgery, Carbon Therapy, CyberKnife, AI-POC, CAR-T Cell Therapy, MR Linac, Nano Robotics, Molecular Diagnostic, Cyto Reductive surgeries, and the ARC Program, have emerged as game-changers in the fight against cancer.
In oncology, MR Linac enhances radiation therapy precision with real-time imaging. Nano robotics enable targeted drug delivery and less invasive procedures, improving treatment accuracy. Molecular diagnostics aid in disease characterization and personalized therapy selection. Cyto-reductive surgeries bolster multidisciplinary cancer management, enhancing patient survival and quality of life, marking a transformative shift in cancer care towards precision and personalized treatment.
Global Perspective on Cancer Care Technological Advancements
According to recent studies by the American Society of Clinical Oncology (ASCO), Proton Therapy has showcased significantly reduced toxicities and improved survival rates in various cancer types. Moreover, advancements in CyberKnife technology have resulted in enhanced precision and minimized radiation exposure for patients undergoing radiotherapy.
The introduction of AI-POC (Artificial Intelligence-Precision Oncology Centre) has revolutionized diagnostic capabilities, enabling early detection and personalized treatment strategies. In January 2024, Apollo Cancer Centres launched India’s first AI-Precision Oncology Centre in Bengaluru. The Centre helps the oncologists, patients and care givers to arrive at the best possible results in a time bound manner, using the enormous possibilities offered by AI.
Asian Perspective on Cancer Care Technological Advancements
In Asia, especially in India, the technological advancements in cancer care have been instrumental in revolutionizing treatment modalities and patient outcomes. Notably, the integration of cutting-edge AI technologies in cancer care settings empowers researchers to identify disease progression trends, predict complications accurately, and develop personalized treatment strategies, exemplifying a paradigm shift in how cancer is diagnosed and treated. Furthermore, initiatives such as the FIRST Cancer Care advocate leveraging technological advancements, emphasizing the transformative potential of innovative approaches to reshape the landscape of cancer care in India. These advancements underscore India's ability to provide world-class cancer care thus positioning the region at the forefront of leveraging technological innovations to improve cancer care and patient outcomes.
Indian Perspective on Cancer Care Technological Advancements
In the context of India, the landscape of cancer care has been significantly influenced by these technological advancements. As per the National Library of Medicine (NLM), robotic surgery leads to shorter hospital stays than the conventional open surgery, reduced surgery-related complications, less pain and faster recovery times for patients. Furthermore, the introduction of CAR-T Cell therapy has shown promising outcomes in the management of hematological malignancies across several leading oncology centres in the country.
In alignment with its unwavering commitment to pioneering cancer care, Apollo Cancer Centres has spearheaded several technological advancements that are redefining the standards of oncology care in India.
Proton Therapy:
Proton Therapy represents a significant advancement in cancer care in India. With state-of-the-art technology, it offers highly precise and effective treatment procedures, elevating standards in surgical, radiation, and medical oncology. This pioneering approach underscores India's progress in adopting advanced cancer care, positioning the Apollo Proton Cancer Centres as a leader in providing world-class treatment and enhancing outcomes for patients across the globe.
CyberKnife Technology:
The CyberKnife Robotic Radiosurgery, a groundbreaking technology that treats tumors with sub-millimeter accuracy, is a notable advancement in cancer care in India. This innovation at Apollo Cancer Centres has led to significant improvements in the precision and effectiveness of radiation treatment. The CyberKnife System plays a pivotal role in enabling Apollo Cancer Centres to offer non-invasive, highly targeted treatment modalities, enhancing the overall outcomes for cancer patients
DREZotomy:
The introduction of India's first Dorsal Root Entry Zone lesioning (DREZotomy) procedure at Apollo Cancer Centres in Chennai marks a significant advancement in cancer care technology. This groundbreaking approach showcases the potential of advanced neurosurgery in relieving cancer-related pain, even in complex cases. The precision required by the DREZotomy underscores Apollo's adoption of innovative methodologies, opening new avenues for addressing cancer-induced pain through neurosurgical interventions.
AI-POC:
The AI Precision Oncology Centre (AI-POC) at Apollo Cancer Centres revolutionizes cancer care in India with advanced AI technology. AI-POC pioneers personalized treatment strategies, optimizing patient outcomes through data-driven interventions. By harnessing AI analytics and predictive modeling, Apollo Cancer Centres transforms cancer diagnosis and treatment planning, enhancing accuracy and efficiency. This marks a revolutionary milestone in oncology, showcasing Apollo's commitment to world-class personalized care for cancer patients in India.
CAR-T Cell Therapy:
In India, the technological advancements in CAR-T Cell Therapy have shown promising outcomes in the treatment of some kinds of lymphomas and leukemia, offering new hope to patients. Apollo Cancer Centres has been at the forefront of this innovation with its CAR-T Cell Therapy program. ACCs has emerged as the first private hospital group in India to have successfully completed CAR-T cell program and to further augment it, the group has started to provide access to ‘Made in India’ CAR-T cell therapy,
beginning with NexCAR19™ (Actalycabtagene autoleucel) for the treatment of B-cell lymphomas and B-acute lymphoblastic leukaemia in patients aged 15 years and above.
ARC Program:
The Apollo Rectal Cancer Program at Apollo Proton Cancer Centres revolutionizes rectal cancer care through advanced technologies like Proton Therapy and Robotic Surgery. These innovations ensure precise treatment delivery, minimize side effects, and enable faster recovery. With a multidisciplinary approach, the program epitomizes the forefront of rectal cancer treatment, combining cutting-edge technology with personalized care.
The integration of cutting-edge technologies such as immune checkpoint inhibitors, CAR-T cell therapy, nanotherapy, and AI-driven precision oncology represents a paradigm shift in how cancer is diagnosed and treated. These advancements not only promise tailored treatments and improved patient outcomes but they also hold the potential to reshape the landscape of cancer care in the country. Collaborative efforts between public and private healthcare sectors, coupled with international partnerships, are driving innovation and ensuring the delivery of state-of-the-art cancer care across India. With a commitment to personalized and multidisciplinary approaches, coupled with investments in research, development, and training, India is poised to emerge as a global leader in affordable and effective cancer care.
(The author is the President-Group Oncology & International, Apollo Hospitals Enterprise Ltd)
.jpg)
_20241220145628_original_image_22.webp)
